Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964)
10/2003
10/30/2003WO2002059607A3 Isolation of epidermal stem cells by using the melanoma-associated chondroitin sulfate proteoglycan
10/30/2003WO2002053703A3 Aav2 vectors and methods
10/30/2003WO2002050243A3 The use of ecm degrading enzymes for the improvement of cell transplantation
10/30/2003WO2002022819A3 Calcium binding proteins
10/30/2003WO2002018583A9 Modified polypeptides stabilized in a desired conformation and methods for producing same
10/30/2003WO2001090302A3 Compositions and methods for production of rna viruses and rna virus-based vector particles
10/30/2003US20030204868 Pseudomonas avr and hop proteins, their encoding nucleic acids, and use thereof
10/30/2003US20030204321 Efficient algorithm for PCR testing of blood samples
10/30/2003US20030204206 Electrically responsive promoter system
10/30/2003US20030204071 109 human secreted proteins
10/30/2003US20030204069 Segments of the human gene for telomerase reverse transcriptase
10/30/2003US20030204068 Nucleotide sequences coding campylobacter proteins for use in preventing bacterial, fungal and viral infection as well as treat gastrointestinal disorders and peptic ulcers; genetic vaccines
10/30/2003US20030204065 Comprises peptidoglycan recognition protein (PGRP) for diagnosis and treatment of blood and tumor disorders
10/30/2003US20030204058 Dendritic enriched secreted lymphocyte activation molecule
10/30/2003US20030204052 Comprises polypeptide for treatment and prevention of autoimmune, cancer, inflammatory, nervous system, cardiomyopathy and atherosclerotic disorders
10/30/2003US20030203871 Novel cationic cholesteryl derivatives containing cyclic polar groups
10/30/2003US20030203870 Method and reagent for the inhibition of NOGO and NOGO receptor genes
10/30/2003US20030203867 NIP3 family of proteins
10/30/2003US20030203865 Lipid-comprising drug delivery complexes and methods for their production
10/30/2003US20030203864 Treatment of cancer
10/30/2003US20030203863 Interleukins (IL-2); cytokines; bovine growth hormone; cytomegalovirus; gene therapy
10/30/2003US20030203861 Nucleic acid vector containing a non-coding, immunostimulatory polynucleotide, comprised of six nucleotides arranged in the sequence 5'-purine-purine-unmethylated CpG-pyrimidine-pyrimidine-3'
10/30/2003US20030203847 Methods and compositions in treating pain and painful disorders using 9949, 14230, 760, 62553, 12216, 17719, 41897, 47174, 33408, 10002, 16209, 314, 636, 27410, 33260, 619, 15985, 69112, 2158, 224, 615, 44373, 95431, 22245, 2387, 16658, 55054, 16314, 1613, 1675, 9569 or 13424 molecules
10/30/2003US20030203844 Administering platelet derived growth factor, endothelial growth factor or a combination to modulate neural stem cell or neural porgenitor cell activity in vivo to a patient suffering from nerveous system disorder or disease
10/30/2003US20030203840 Nucleic acid containing at least one adenine base, a guanine base, a cytosine base, and at least thymin or uracil base and nucleic acid is atleast 12 bases in length, hybridizes to sense or antisense strand of second nucleic acid
10/30/2003US20030203838 Compositions and methods for inhibiting angiogenesis
10/30/2003US20030203489 Pseudotype retroviral vectors containing membrane proteins having hemagglutinin activity
10/30/2003US20030203488 Plasmid comprising components from herpesvirus, cytomegalovirus, adeno-associated virus, poxvirus and adenovirus which permits the transfer and expression of genes of interest in preferential cells
10/30/2003US20030203484 Inducing differentiation of isolated marrow stromal cell into a neuronal cell using neuronal differentiation-inducing compound such as dimethylsulfoxide and butylated hydroxyanisole for treating nervous system disorders
10/30/2003US20030203482 Stimulation of cellular regeneration and differentiation tn the inner ear
10/30/2003US20030203472 Episome for transfer and expression of heterologous nucleotide sequences in gram positive bacteria; genetic vaccines
10/30/2003US20030203463 Nucleotide sequence which encodes a flavin monooxygenase, the corresponding protein and their uses in the spheres of diagnosis and therapy
10/30/2003US20030203452 Human chemokine beta-13
10/30/2003US20030203426 Comprises proteins for diagnosis, treatment and prevention of arthritis, muscular, cancer, nervous system, sex and urogenital disorders
10/30/2003US20030203402 Secreted and transmembrane polypeptides and nucleic acids encoding the same
10/30/2003US20030203361 13 human colon and colon cancer associated proteins
10/30/2003US20030202991 Delivery of biologically active polypeptides
10/30/2003US20030202989 Use of toxin peptides and/or affinity handles for delivering compounds into cells
10/30/2003US20030202988 Attenuated mutant; induce immunology response
10/30/2003US20030202971 Genetic engineering; binding polypeptide to antibody ; screening, modulation, calibration
10/30/2003US20030202970 Carboxymethylcellulose sponges, membranes, gels, particles; anticoagualnts, drug delivery
10/30/2003US20030202967 Diabetic therapy
10/30/2003US20030202966 Isolated stromal cells and methods of using the same
10/30/2003US20030202964 Mutated herpes simplex virus type 1 thymidine kinases and uses thereof
10/30/2003US20030202963 Method of treating cancer
10/30/2003US20030202962 Antigen encoded nucleic acids; controlling cell differentiation, cell proliferation; transcription factor controller
10/30/2003US20030202960 Therapeutic angiogenic factors and methods for their use
10/30/2003CA2483327A1 Oligonucleotides from coding sequences for the surface component of ptlvenvelope proteins and uses thereof
10/30/2003CA2483010A1 Placental derived stem cells and uses thereof
10/30/2003CA2482993A1 Inhibition of ii expression in mammalian cells
10/30/2003CA2482909A1 Tocopherol associated protein and uses thereof
10/30/2003CA2482907A1 Tissue specific genes and gene clusters
10/30/2003CA2482719A1 Conjugates of membrane translocating agents and pharmaceutically active agents
10/30/2003CA2482183A1 Method of treating biological materials with translating electrical fields and electrode polarity reversal
10/30/2003CA2481986A1 Surface transfection and expression procedure
10/30/2003CA2481724A1 Screening and therapeutic methods for treating circadian rhythm disorders
10/30/2003CA2480437A1 Methods of identifying compounds that modulate a dna repair pathway and/or retroviral infectivity, the compounds, and uses thereof
10/30/2003CA2480404A1 Fc receptor homolog, reagents, and uses thereof
10/29/2003EP1357184A2 Novel cis-element decoys useful as anti-tumor therapeutics
10/29/2003EP1356820A1 DNA vaccine combined with an inducer of tumor cell apoptosis
10/29/2003EP1356818A2 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
10/29/2003EP1356284A2 Schizophrenia related genes
10/29/2003EP1356278A2 Methods and compositions for the identification and treatment of neurodegenerative disorders
10/29/2003EP1356277A2 Method for altering cell fate
10/29/2003EP1356110A2 Non-invasive method for detecting target rna
10/29/2003EP1356108A2 Expression analysis of fkbp nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
10/29/2003EP1356095A2 Method for identifying metastatic tumor cells
10/29/2003EP1356091A2 Method of detecting inflammatory lung disorders
10/29/2003EP1356079A2 Srebp pathway modulation through targeting hisrs
10/29/2003EP1356071A2 Genetically engineered herpes virus for the treatment of cardiovascular disease
10/29/2003EP1356070A2 Conditionally replicating viral vectors and their use
10/29/2003EP1356047A2 Human proteins, polynucleotides encoding them and methods of using the same
10/29/2003EP1356043A2 Novel proteins and nucleic acids encoding same and antibodies directed against these proteins
10/29/2003EP1356039A2 Down syndrome critical region 1-like 1 proteins
10/29/2003EP1356038A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1356030A1 Runx3 gene showing anti-tumor activity and use thereof
10/29/2003EP1355946A1 Dna vaccines expressing hypervariable vh-cdr3 idiotipic determinants
10/29/2003EP1355934A2 Compositions and methods relating to lung specific genes and proteins
10/29/2003EP1355928A1 Universal carrier for targeting molecules to gb3 receptor expressing cells
10/29/2003EP1355926A2 Therapeutic compounds for ovarian cancer
10/29/2003EP1355922A2 Stress proteins and peptides and methods of use thereof
10/29/2003EP1355921A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof
10/29/2003EP1355676A2 Protecting therapeutic compositions from host-mediated inactivation
10/29/2003EP1355670A2 Enhanced stabilised plasmid-lipid particle-mediated transfection using endosomal membrane destabilisers
10/29/2003EP1355669A2 Augmented cognitive training
10/29/2003EP1355668A1 Use of il-18 inhibitors for the treatment and/or prevention of heart disease
10/29/2003EP1355666A2 Use of rgm and its modulators
10/29/2003EP1355659A2 Use of compositions containing pdgf-bb for promoting angiogenesis
10/29/2003EP1355655A2 Compositions and methods for improving kidney function
10/29/2003EP1355653A2 Stimulation of thymus for vaccination development
10/29/2003EP1355628A2 Stabilised polymeric aerosols for pulmonary gene delivery
10/29/2003EP1355566A2 Local regional chemotherapy and radiotherapy using in situ hydrogel
10/29/2003EP1355563A2 METHODS FOR THE PREVENTION AND TREATMENT OF CANCER USING ANTI-C3B(i) ANTIBODIES
10/29/2003EP0951553B1 Adenovirus e4 proteins for inducing cell death
10/29/2003EP0941122B1 Compositions for polynucleotide delivery
10/29/2003EP0941066B1 Cationic lipid-nucleic acid complexes
10/29/2003EP0922114B1 Catalytic nucleic acid and its medical use
10/29/2003CN1452661A Viral vectors for use in monitoring HIV drug resistance
10/29/2003CN1452496A Use of strains of parapox ovis virus against organ fibrosis
10/29/2003CN1451752A Control of LAP-to-LIP ratio
1 ... 485 486 487 488 489 490 491 492 493 494 495 496 497 498 499 500 501 502 503 504 505 ... 870